Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
A lot of dermatologists don't feel comfortable diagnosing and treating psoriasis in patients with skin of color, says Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology. Shahriari has always had an interest in inflammatory skin disease, particularly in patients with melanin rich skin and how to treat these patients who may be facing burdens in receiving care.
Transcript
Can you provide an overview of your presentation at the 2023 Fall Clinical Dermatology Conference on the treatment of plaque psoriasis in patients with skin of color? What unique challenges or nuances were addressed?
I have always had a strong interest in inflammatory skin disease, but in particular, in patients with skin of color, just because in my neck of the woods, I was never trying to be a skin of color expert, but people saw my skin color. So they said, she probably knows how to treat our skin. And they would just flock to me. So, little by little, I had to learn more about how to treat different skin conditions in patients with melanin rich skin.
And what I find is, we don't actually get a lot of training in our residences, things are changing. Now, I'd say in the year 2023, we definitely have a lot more resources at our disposal. But when I was undergoing residency, I won't tell you how long ago, it was not something that was readily available as part of our curriculum. It wasn't something that I would see in my everyday clinical practice. And if I was interested, I had to seek it out myself. And I think that really contributes to some of the disparities that we're seeing in the treatment of plaque psoriasis in our patients with skin color. Because for starters, the social determinants of health are going to lead to issues in terms of patients actually getting to a specialist. Maybe they're in a geographic region where they don't have access to a specialist, maybe due to economic reasons they can't take time off of work to go see a specialist during business hours, so they end up getting paired care in an ER or an urgent care setting where a specialist obviously is not available.
But for those patients that overcome those hurdles, and they actually make it to a dermatologists office, a lot of the [dermatologists] don't feel comfortable diagnosing and treating psoriasis and skin color. Now they're either being incorrectly diagnosed or they're being under-treated because disease severity is being assessed incorrectly, or the treatments that are out there. If the provider doesn't know how to properly educate the patient on the treatments, there may be this sense of distrust between the provider and the patient. And then they can never embark on those new emerging therapies that can be really game changing for that particular patient. So this has definitely been an area of immense research and interest. So we're going to really dive deeper into how we can help bridge the gaps and allow for patients to delay patients to receive more inclusive care.
Study Validates Smartphone Analysis for Predicting Obstructive Sleep Apnea
November 29th 2023Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional in-laboratory polysomnography.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Study Finds Link Between Depression, Functional Impairment in Psoriasis, Psoriatic Arthritis
November 24th 2023Depression symptoms are often underdiagnosed and undertreated in patients with psoriasis and psoriatic arthritis, contributing to a worsened quality of life (QOL). However, a recent study found that depression, functional impairment, and worsened QOL are related.
Read More
Dupilumab Efficacy, Reduced Corticosteroid Use in Children With Moderate to Severe Asthma
November 22nd 2023Posters presented at ACAAI 2023 Annual Scientific Congress examined dupilumab use in children with moderate-to-severe asthma and in the presence of elevated type 2 biomarkers.
Read More